Pancreatic ductal adenocarcinoma is a malignancy with a high mortality rate. It exhibits significant heterogeneity in metabolic pathways which are associated with its progression. In this review, we discuss the role of single cell RNA sequencing in unraveling the metabolic and clinical features of these highly malignant tumors
This work utilizes single cell RNA sequencing to identify transcriptional populations and gene chang...
Pancreatic ductal adenocarcinoma (PDAC) is characterized by intra-tumoral heterogeneity, and patient...
Pancreatic cancer is a lethal disease with increasing incidence and high recurrence rates, currently...
Abstract Pancreatic ductal adenocarcinoma (PDAC) is the most frequent and aggressive pancreatic tumo...
BackgroundPancreatic ductal adenocarcinoma (PDAC) is an extremely deadly neoplasm, with only a 5-yea...
BackgroundPancreatic ductal adenocarcinoma (PDAC) is an extremely deadly neoplasm, with only a 5-yea...
BackgroundPancreatic ductal adenocarcinoma (PDAC) is an extremely deadly neoplasm, with only a 5-yea...
BackgroundPancreatic ductal adenocarcinoma (PDAC) is an extremely deadly neoplasm, with only a 5-yea...
Pancreatic cancer represents one of the most lethal disease worldwide but still orphan of a molecula...
Pancreatic duct adenocarcinoma (PDAC) is an aggressive and lethal malignancy. Pancreatic cancer stem...
The aim of the current study was to implement whole transcriptome massively parallel sequencing (RNA...
Context Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy with few effective the...
Pancreatic ductal adenocarcinoma (PDAC) is predicted to become the second leading cause of cancer-re...
Context: Pancreatic cancer (PC) is characterized by a 5 year survival rate of 4%. The molecular mech...
These data are collected and integrated from five available deposit data and one original data of si...
This work utilizes single cell RNA sequencing to identify transcriptional populations and gene chang...
Pancreatic ductal adenocarcinoma (PDAC) is characterized by intra-tumoral heterogeneity, and patient...
Pancreatic cancer is a lethal disease with increasing incidence and high recurrence rates, currently...
Abstract Pancreatic ductal adenocarcinoma (PDAC) is the most frequent and aggressive pancreatic tumo...
BackgroundPancreatic ductal adenocarcinoma (PDAC) is an extremely deadly neoplasm, with only a 5-yea...
BackgroundPancreatic ductal adenocarcinoma (PDAC) is an extremely deadly neoplasm, with only a 5-yea...
BackgroundPancreatic ductal adenocarcinoma (PDAC) is an extremely deadly neoplasm, with only a 5-yea...
BackgroundPancreatic ductal adenocarcinoma (PDAC) is an extremely deadly neoplasm, with only a 5-yea...
Pancreatic cancer represents one of the most lethal disease worldwide but still orphan of a molecula...
Pancreatic duct adenocarcinoma (PDAC) is an aggressive and lethal malignancy. Pancreatic cancer stem...
The aim of the current study was to implement whole transcriptome massively parallel sequencing (RNA...
Context Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy with few effective the...
Pancreatic ductal adenocarcinoma (PDAC) is predicted to become the second leading cause of cancer-re...
Context: Pancreatic cancer (PC) is characterized by a 5 year survival rate of 4%. The molecular mech...
These data are collected and integrated from five available deposit data and one original data of si...
This work utilizes single cell RNA sequencing to identify transcriptional populations and gene chang...
Pancreatic ductal adenocarcinoma (PDAC) is characterized by intra-tumoral heterogeneity, and patient...
Pancreatic cancer is a lethal disease with increasing incidence and high recurrence rates, currently...